Company Announcements

Notice of Capital Markets Day and Trading Update

Source: RNS
RNS Number : 3631F
Marlowe PLC
21 March 2022
 

21 March 2022

 

Marlowe plc

 

Notice of Capital Markets Day and Trading Update

 

Marlowe plc ("Marlowe" or the "Group"), the UK leader in business-critical services and software which assure safety and regulatory compliance, will be hosting a virtual Capital Markets Day along with Q&A for investors and analysts on Tuesday, 5 April 2022.

 

Capital Markets Day

 

At the event, senior executives and operational management will provide an update on:

 

·      The significant progress made in building the Marlowe compliance platform and delivering against the Group's medium-term financial and strategic targets set out at our last Capital Markets Day (17 February 2021); and

 

·      A deep-dive into the Group's Governance, Risk and Compliance division focusing on our software and consultancy offering.

 

The event will start at 10:00 GMT and is expected to end at around 12:00 GMT.

 

Please register for the live webcast using this link:

 

https://www.investis-live.com/marloweplc/62320b81f1e36c0c0070c589/lkop 

A video replay of the presentation will be available on the Marlowe website post-event.

 

Group trading

 

The Group continues to make strong financial and strategic progress, and trading for the year ending 31 March 2022 is expected to be in line with current market expectations.

 

The integration programmes of all recent completed acquisitions are proceeding as planned with synergies being delivered in line with expectations. In addition, the Group's pipeline of earnings-enhancing acquisitions remains attractive and the Group is in a strong financial position to capitalise on these opportunities as they arise.

 

 

For further information:

 

Marlowe plc

Alex Dacre, Chief Executive

www.marloweplc.com

Adam Councell, Chief Financial Officer

Tel: +44 (0) 203 813 8498

Julian Wais, Head of Investor Relations

IR@marloweplc.com

Benjamin Tucker, Investor Relations Manager

 

 

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

Nicholas Wells

Tel: +44 (0)20 7397 8900

Ben Jeynes

 

 

 

Berenberg (Joint Broker)

Ben Wright

Tel: +44 (0)20 3207 7800

Mark Whitmore

 

 

 

Stifel (Joint Broker)

Matthew Blawat

Tel: +44 (0)20 7710 7688

Francis North

 

 

 

FTI Consulting

 

Nick Hasell

Tel: +44 (0)20 3727 1340

Alex Le May

 

     

 

About Marlowe plc

 

Marlowe is a UK leader in business-critical services and software which assure safety and regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services. It is focused on compliance software, eLearning, health & safety, employment law and HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets and leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKDEALNAEFA